RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32155332http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32155332http://www.w3.org/2000/01/rdf-schema#comment"Autoantibody signatures of circulating mucin fragments stem from cancer tissues, and microenvironments are promising biomarkers for cancer diagnosis and therapy. This study highlights dynamic epitopes generated by aberrantly truncated immature O-glycosylation at consecutive threonine motifs (TTX) found in mucins and intrinsically disordered proteins (IDPs). NMR analysis of synthetic mucin models having glycosylated TTX motifs and colonic MUC2 tandem repeats (TRs) containing TTP and TTL moieties unveils a general principle that O-glycosylation at TTX motifs generates a highly extended and rigid conformation in IDPs. We demonstrate that the specific conformation of glycosylated TTX motifs in MUC2 TRs is rationally rearranged by concerted motions of multiple dihedral angles and noncovalent interactions between the carbohydrate and peptide region. Importantly, this canonical conformation of glycosylated TTX motifs minimizes steric crowding of glycans attached to threonine residues, in which O-glycans possess restricted orientations permitting further sugar extension. An antiadhesive microarray displaying synthetic MUC2 derivatives elicited the presence of natural autoantibodies to MUC2 with impaired O-glycosylation at TTX motifs in sera of healthy volunteers and patients diagnosed with early stage colorectal cancer (CRC). Interestingly, autoantibody levels in sera of the late stage CRC patients were distinctly lower than those of early stage CRC and normal individuals, indicating that the anti-MUC2 humoral response to MUC2 neoepitopes correlates inversely with the CRC stage of patients. Our results uncovered the structural basis of the creation of dynamic epitopes by immature O-glycosylation at TTX motifs in mucins that facilitates the identification of high-potential targets for cancer diagnosis and therapy."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.org/dc/terms/identifier"doi:10.1021/acs.biochem.0c00007"xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Matsuoka K."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Wakui H."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Taketomi A."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Matsushita T."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Hayakawa S."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Kamiyama T."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Yokoi Y."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Garcia-Martin F."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Nishimura S.I."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Nouso K."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/author"Hinou H."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/name"Biochemistry"xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/pages"1221-1241"xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/title"Impaired O-Glycosylation at Consecutive Threonine TTX Motifs in Mucins Generates Conformationally Restricted Cancer Neoepitopes."xsd:string
http://purl.uniprot.org/citations/32155332http://purl.uniprot.org/core/volume"59"xsd:string
http://purl.uniprot.org/citations/32155332http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32155332
http://purl.uniprot.org/citations/32155332http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32155332
http://purl.uniprot.org/uniprot/#_A0A3S8TMF2-mappedCitation-32155332http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32155332
http://purl.uniprot.org/uniprot/#_O00243-mappedCitation-32155332http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32155332
http://purl.uniprot.org/uniprot/#_Q14883-mappedCitation-32155332http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32155332
http://purl.uniprot.org/uniprot/#_Q14884-mappedCitation-32155332http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32155332